Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms

Low-density lipoprotein and ritonavir: an interaction between antiretrovirals and lipids mediated by P-glycoprotein

(2014) Massimo Tempestilli et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients

(2013) A. Calcagno et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells

(2012) A. D'Avolio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of the Mean Corpuscular Volume of Peripheral Blood Mononuclear Cells of HIV Patients by a Coulter Counter To Determine Intracellular Drug Concentrations

(2011) Marco Simiele et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetic Modeling of the Association between 63396C->T Pregnane X Receptor Polymorphism and Unboosted Atazanavir Clearance

(2010) A. Schipani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A HPLC–MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation

(2010) Antonio D’Avolio et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir

(2010) Rubin Lubomirov et al.   Pharmacogenetics and Genomics

Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir

(2010) I. F. Sevrioukova et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function

(2009) King Leung Fung et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

The impact ofSLCO1B1polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men

(2009) Fabiana B. Kohlrausch et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action

(2009) Caroline Bazzoli et al.   CLINICAL PHARMACOKINETICS

Analysis of CYP3A4-HIV-1 protease drugs interactions by computational methods for Highly Active Antiretroviral Therapy in HIV/AIDS

(2009) Mannu Jayakanthan et al.   JOURNAL OF MOLECULAR GRAPHICS & MODELLING

Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir

(2008) O Janneh et al.   BRITISH JOURNAL OF PHARMACOLOGY

Association of a Single‐Nucleotide Polymorphism in the Pregnane X Receptor (PXR63396C→T) with Reduced Concentrations of Unboosted Atazanavir

(2008) Marco Siccardi et al.   CLINICAL INFECTIOUS DISEASES

Organic Anion Transporter 1B1: An Important Factor in Hepatic Thyroid Hormone and Estrogen Transport and Metabolism

(2008) Wendy M. van der Deure et al.   ENDOCRINOLOGY

An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients

(2008) Antonio DʼAvolio et al.   THERAPEUTIC DRUG MONITORING

Drug Interactions between Warfarin and Efavirenz or Lopinavir-Ritonavir in Clinical Treatment

(2007) S. Bonora et al.   CLINICAL INFECTIOUS DISEASES

Global analysis of genetic variation in SLCO1B1

(2007) Marja K Pasanen et al.   PHARMACOGENOMICS